Bilcare Ltd (BI) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 805987, "name": "Bilcare", "stock_name": "Bilcare", "full_name": "Bilcare Ltd", "name_url": "stocks-analysis/bilcare", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "56.90", "chg": 0.62, "chgp": "1.1%", "dir": 1, "prev_price": "56.28", "mcapval": "133.97 Cr", "mcap": "Micro Cap", "scripcode": 526853, "symbol": "BI", "ind_name": "Healthcare Services", "ind_code": 43, "sector_id": 35, "indexname": "India SENSEX", "isin": "INE986A01012", "curr_date": "Jun 25, 11:16 AM", "curr_time": "11:17 AM", "last_traded_at": "Jun 25, 11:16 AM IST", "bse_nse_vol": "3.67 k", "exc_status": "Active", "traded_date": "Jun 25, 2026", "traded_date_str": "2026 06 25", "score": "", "scoreText": "", "Live": 1, "market_time": 1, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/bilcare-805987-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Bilcare Ltd is Rated Sell by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/bilcare-ltd-is-rated-sell-by-marketsmojo-4055974", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BilcareLtd_mojoScore_4055974.png", "date": "2026-06-16 10:10:04", "description": "Bilcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 02 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 16 June 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance." }, { "title": "Bilcare Ltd Valuation Shifts Signal Renewed Price Attractiveness Amid Market Challenges", "link": "https://www.marketsmojo.com/news/stocks-in-action/bilcare-ltd-valuation-shifts-signal-renewed-price-attractiveness-amid-market-challenges-4054874", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BilcareLtd_valuationdot_4054874.png", "date": "2026-06-16 08:01:28", "description": "Bilcare Ltd, a micro-cap player in the Healthcare Services sector, has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating. Despite recent price declines and underperformance relative to the Sensex, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios suggest a more compelling entry point for investors seeking value in a challenging market environment." }, { "title": "Bilcare Ltd Gains 2.92%: 3 Key Factors Driving the Weekly Move", "link": "https://www.marketsmojo.com/news/stocks-in-action/bilcare-ltd-gains-292-3-key-factors-driving-the-weekly-move-4052213", "imagepath": "", "date": "2026-06-13 17:07:48", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>1 June:</strong> Q4 FY26 results reveal sharp profit turnaround despite operational concerns</p>\n <p><strong>2 June:</strong> Strong quarterly financial turnaround reported amid market challenges</p>\n <p><strong>3 June:</strong> Valuation shifts signal renewed price attractiveness amid mixed returns</p>\n <p><strong>5 June:</strong> Week closes at Rs.63.87, up 2.92% for the week</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.62.06</div></div>\n <div class=\"stat-item\"><div class=\"s..." }, { "title": "Bilcare Ltd Valuation Shifts: From Attractive to Fair Amidst Market Challenges", "link": "https://www.marketsmojo.com/news/stocks-in-action/bilcare-ltd-valuation-shifts-from-attractive-to-fair-amidst-market-challenges-4040001", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BilcareLtd_valuationdot_4040001.png", "date": "2026-06-09 08:00:39", "description": "Bilcare Ltd, a micro-cap player in the Healthcare Services sector, has seen a notable shift in its valuation parameters, moving from an attractive to a fair rating. This change reflects evolving market perceptions amid subdued financial performance and challenging sector dynamics, prompting a reassessment of its price attractiveness relative to peers and historical benchmarks." }, { "title": "Bilcare Ltd is Rated Sell by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/bilcare-ltd-is-rated-sell-by-marketsmojo-4037926", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BilcareLtd_mojoScore_4037926.png", "date": "2026-06-05 10:10:05", "description": "Bilcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 02 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 June 2026, providing investors with the most up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook." }, { "title": "Bilcare Ltd Valuation Shifts Signal Renewed Price Attractiveness Amid Mixed Returns", "link": "https://www.marketsmojo.com/news/stocks-in-action/bilcare-ltd-valuation-shifts-signal-renewed-price-attractiveness-amid-mixed-returns-4032750", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BilcareLtd_valuationdot_4032750.png", "date": "2026-06-03 08:01:22", "description": "Bilcare Ltd has witnessed a notable shift in its valuation parameters, moving from a risky to an attractive valuation grade, despite lingering challenges in profitability metrics. This recalibration in price-to-earnings and price-to-book ratios, alongside peer comparisons, offers investors a fresh perspective on the stock’s price attractiveness within the healthcare services sector." }, { "title": "Are Bilcare Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-bilcare-ltd-latest-results-good-or-bad-4032445", "imagepath": "", "date": "2026-06-02 19:35:11", "description": "Bilcare Ltd's latest financial results for Q4 FY26 present a complex picture characterized by significant contrasts. The company reported a consolidated net profit of ₹13.37 crores, which reflects a substantial quarter-on-quarter increase, reversing losses from the previous quarter. However, this profit is down compared to the same quarter last year, indicating ongoing challenges in maintaining consistent profitability.\n\nNet sales for the quarter reached ₹187.66 crores, marking a modest sequential growth of 3.50% from the previous quarter, but this also represents a year-on-year decline of 3.28%. This trend suggests that while there is some recovery in sales, the company is struggling to regain the momentum it previously enjoyed, as evidenced by sales figures that have not returned to levels above ₹200 crores seen in earlier periods.\n\nThe operating margin, excluding other income, improved to 9.02%, the high..." }, { "title": "Bilcare Ltd Reports Strong Quarterly Financial Turnaround Amid Market Challenges", "link": "https://www.marketsmojo.com/news/stocks-in-action/bilcare-ltd-reports-strong-quarterly-financial-turnaround-amid-market-challenges-4028952", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BilcareLtd_fintrenddot_4028952.png", "date": "2026-06-02 08:00:14", "description": "Bilcare Ltd, a micro-cap player in the Healthcare Services sector, has demonstrated a notable improvement in its financial performance for the quarter ended March 2026, signalling a positive shift in its financial trend after a period of stagnation. Despite this, the company’s stock continues to face challenges in the broader market context, with returns lagging behind benchmark indices over the year-to-date and one-year periods." }, { "title": "Bilcare Q4 FY26: Sharp Profit Turnaround Masks Underlying Operational Concerns", "link": "https://www.marketsmojo.com/news/result-analysis/bilcare-q4-fy26-sharp-profit-turnaround-masks-underlying-operational-concerns-4030694", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/Bilcare_quaterlyResult_4030694.png", "date": "2026-06-01 21:17:25", "description": "Bilcare Ltd., a speciality pharmaceutical packaging barrier films manufacturer, reported a dramatic quarterly profit turnaround in Q4 FY26 with consolidated net profit of ₹13.37 crores, marking a staggering 1278.35% quarter-on-quarter surge from ₹0.97 crores in Q3 FY26. However, the year-on-year comparison reveals a 23.95% decline from ₹17.58 crores in Q4 FY25, highlighting persistent challenges beneath the surface-level recovery. The stock, currently trading at ₹63.20 with a micro-cap market capitalisation of ₹155.00 crores, has underperformed significantly over the past year with a 23.14% decline against the Sensex's 8.82% fall." } ], "total": 180, "sid": "805987", "stock_news_url": "https://www.marketsmojo.com/news/bilcare-805987" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "23-Jun-2026", "details": "Bilcare Limited has informed the Exchange about Newspaper Publication regarding Postal Ballot Notice and Remote e-voting.", "source": "BSE" }, { "caption": "Shareholder Meeting / Postal Ballot-Notice of Postal Ballot", "datetime": "22-Jun-2026", "details": "Bilcare Limited has informed the Exchange about Notice of Postal Ballot.", "source": "BSE" }, { "caption": "Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015", "datetime": "12-Jun-2026", "details": "Bilcare Limited has submitted to the Exchange about the disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regualtions 2015 - Order of Honble NCLT Mumbai Bench.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Bilcare Ltd has declared <strong>20%</strong> dividend, ex-date: 20 Sep 12", "dt": "2012-09-20", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

1 June: Q4 FY26 results reveal sharp profit turnaround despite operational concerns

2 June: Strong quarterly financial turnaround reported amid market challenges

3 June: Valuation shifts signal renewed price attractiveness amid mixed returns

5 June: Week closes at Rs.63.87, up 2.92% for the week

Week Open

Rs.62.06

Read full news article

Bilcare Ltd Valuation Shifts: From Attractive to Fair Amidst Market Challenges

2026-06-09 08:00:39

Bilcare Ltd, a micro-cap player in the Healthcare Services sector, has seen a notable shift in its valuation parameters, moving from an attractive to a fair rating. This change reflects evolving market perceptions amid subdued financial performance and challenging sector dynamics, prompting a reassessment of its price attractiveness relative to peers and historical benchmarks.

Read full news article

Bilcare Ltd is Rated Sell by MarketsMOJO

2026-06-05 10:10:05

Bilcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 02 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 June 2026, providing investors with the most up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Read full news article

Bilcare Ltd Valuation Shifts Signal Renewed Price Attractiveness Amid Mixed Returns

2026-06-03 08:01:22

Bilcare Ltd has witnessed a notable shift in its valuation parameters, moving from a risky to an attractive valuation grade, despite lingering challenges in profitability metrics. This recalibration in price-to-earnings and price-to-book ratios, alongside peer comparisons, offers investors a fresh perspective on the stock’s price attractiveness within the healthcare services sector.

Read full news article

Are Bilcare Ltd latest results good or bad?

2026-06-02 19:35:11

Bilcare Ltd's latest financial results for Q4 FY26 present a complex picture characterized by significant contrasts. The company reported a consolidated net profit of ₹13.37 crores, which reflects a substantial quarter-on-quarter increase, reversing losses from the previous quarter. However, this profit is down compared to the same quarter last year, indicating ongoing challenges in maintaining consistent profitability. Net sales for the quarter reached ₹187.66 crores, marking a modest sequential growth of 3.50% from the previous quarter, but this also represents a year-on-year decline of 3.28%. This trend suggests that while there is some recovery in sales, the company is struggling to regain the momentum it previously enjoyed, as evidenced by sales figures that have not returned to levels above ₹200 crores seen in earlier periods. The operating margin, excluding other income, improved to 9.02%, the high...

Read full news article

Bilcare Ltd Reports Strong Quarterly Financial Turnaround Amid Market Challenges

2026-06-02 08:00:14

Bilcare Ltd, a micro-cap player in the Healthcare Services sector, has demonstrated a notable improvement in its financial performance for the quarter ended March 2026, signalling a positive shift in its financial trend after a period of stagnation. Despite this, the company’s stock continues to face challenges in the broader market context, with returns lagging behind benchmark indices over the year-to-date and one-year periods.

Read full news article

Bilcare Q4 FY26: Sharp Profit Turnaround Masks Underlying Operational Concerns

2026-06-01 21:17:25

Bilcare Ltd., a speciality pharmaceutical packaging barrier films manufacturer, reported a dramatic quarterly profit turnaround in Q4 FY26 with consolidated net profit of ₹13.37 crores, marking a staggering 1278.35% quarter-on-quarter surge from ₹0.97 crores in Q3 FY26. However, the year-on-year comparison reveals a 23.95% decline from ₹17.58 crores in Q4 FY25, highlighting persistent challenges beneath the surface-level recovery. The stock, currently trading at ₹63.20 with a micro-cap market capitalisation of ₹155.00 crores, has underperformed significantly over the past year with a 23.14% decline against the Sensex's 8.82% fall.

Read full news article